Induction chemotherapy with Docetaxel, Cisplatin and Cetuximab results in improved response rates if compared to Docetaxel, Cisplatin and 5-FU for locally advanced or inoperable squamous cell carcinoma of the head and neck: promising results of the Austrian multicentric phase II trial (AGMT)

Keil, F; Hartl, M; Altorjai, G; Pecherstorfer, M; Berghold, A; Riedl, R; De Vries, A; Mayrbaurl, B; Fridrik, MA; Fureder, T; Burian, M; Greil, R

View this publication in the PUBMED database